Definium Therapeutics, Inc.
DFTX
$42.63
-$1.27-2.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.08B | 373.42M | 411.59M | 209.07M | 182.99M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8.22M | 7.14M | 7.73M | 6.78M | 6.14M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.09B | 380.56M | 419.32M | 215.85M | 189.14M |
|
|
|||||
| Total Current Assets | 1.09B | 380.56M | 419.32M | 215.85M | 189.14M |
| Net Property, Plant & Equipment | -- | -- | -- | 600.00K | -- |
| Long-term Investments | 19.92M | 19.92M | 19.92M | 19.92M | 19.92M |
| Goodwill | 19.92M | 19.92M | 19.92M | 19.92M | 19.92M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 880.00K | 812.00K | 862.00K | 550.00K | 1.17M |
| Total Assets | 1.11B | 401.29M | 440.10M | 236.92M | 265.09M |
|
|
|||||
| Total Accounts Payable | 6.97M | 7.13M | 5.35M | 8.11M | 4.22M |
| Total Accrued Expenses | 37.22M | 24.51M | 20.45M | 18.95M | 14.74M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 81.00K | 57.00K |
| Total Finance Division Other Current Liabilities | 113.02M | 49.47M | 40.91M | 38.28M | 18.94M |
| Total Other Current Liabilities | 113.02M | 49.47M | 40.91M | 38.28M | 18.94M |
| Total Current Liabilities | 157.20M | 81.11M | 66.70M | 65.42M | 37.96M |
|
|
|||||
| Total Current Liabilities | 157.20M | 81.11M | 66.70M | 65.42M | 37.96M |
| Long-Term Debt | 36.47M | 40.77M | 40.58M | 40.39M | 41.19M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 519.00K | 543.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 549.00K | 559.00K | 496.00K | -- | -- |
| Total Liabilities | 194.22M | 122.44M | 107.77M | 106.32M | 79.69M |
|
|
|||||
| Common Stock & APIC | 1.74B | 937.80M | 913.91M | 661.83M | 649.56M |
| Retained Earnings | -818.76M | -659.77M | -582.67M | -532.24M | -464.97M |
| Treasury Stock & Other | 417.00K | 824.00K | 1.09M | 1.00M | 807.00K |
| Total Common Equity | 918.68M | 278.85M | 332.33M | 130.60M | 185.40M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 918.68M | 278.85M | 332.33M | 130.60M | 185.40M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 918.68M | 278.85M | 332.33M | 130.60M | 185.40M |
|
|
|||||